Researchers reveal how a gene mutation can lead to devastating blood diseases
Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...
How former leaders of a sold-off biotech company landed their drugs again
South San Francisco biotech Pionyr was sold two years ago. Now three of its leaders want to test a trio of drugs beyond ...
Medscape2 天
To Combat Leukemia, Researchers Harness CD37
Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.
News Medical on MSN6 天
Mutation in ASXL1 gene triggers chain reaction leading to blood disorders
Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off a dangerous chain of ...
Targeted Oncology1 天
LYT-200 Gains FDA Fast Track Status in Acute Myeloid Leukemia
LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for ...
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in Q4 2024, and Genenta expects to treat six patients by the end of the first half of 2025, while continuing progress ...